Purdue University Recognizes World Parkinson’s Day by Highlighting Research Led by PVM Scholar

illustration of a brain
Purdue University researcher Jessica Sonia Fortin, assistant professor of basic medical sciences, physiology and pharmacology, and her collaborators are creating multiple patent-pending compounds to treat Alzheimer’s disease, Parkinson’s disease, and Type 2 diabetes. The compounds inhibit protein aggregation in the brain and pancreas associated with the diseases. iStock illustration provided/Jolygon

World Parkinson’s Day is an annual global healthcare event to recognize the cultural, economic, and social impact of Parkinson’s disease. This year, April 11 was designated as World Parkinson’s Day, which also focuses on advancing the acceptance, inclusion, and support of people affected by the disease.  In recognition of the day, Purdue University spotlighted research by Dr. Jessica Fortin, assistant professor of basic medical sciences, physiology and pharmacology in the College of Veterinary Medicine’s Department of Basic Medical Sciences. 

Parkinson’s disease is one of the world’s most common neurological diseases. The Parkinson’s Foundation reports that nearly one million Americans and more than 10 million people worldwide live with Parkinson’s. Symptoms include uncontrollable or unintended movement and difficulty talking and walking.

Dr. Jessica Sonia Fortin, assistant professor, Department of Basic Medical Sciences
Dr. Jessica Sonia Fortin, assistant professor, Department of Basic Medical Sciences

The aggregation of proteins, including certain hormones, is a common trait in the development of both Parkinson’s and Alzheimer’s. Dr. Fortin is doing patent-pending work to inhibit protein aggregation in the brain. A member of the Purdue Institute for Drug Discovery, Dr. Fortin leads a team preparing new small-molecule compounds and their validation through in vitro studies to inhibit the aggregation of several proteins.

“We aim to offer small-molecule therapeutics that not only prevent aggregation, but also disaggregate already-existing clumps,” Dr. Fortin said. “The body can then eliminate these byproducts and the dual action of these compounds can impede the redistribution of the clumps alongside blood vessels; the risk of such redistribution is intracranial hemorrhage in the brain.”

Dr. Fortin and her colleagues have synthesized a library of small-molecule compounds with anti-inclusion and anti-seeding activities. These activities were investigated in collaboration with Ulf Dettmer of Harvard Medical School and Cristian Lasagna-Reeves of the Indiana University School of Medicine, respectively.

Dr. Fortin disclosed the compounds to the Purdue Innovates Office of Technology Commercialization, which has applied for patents through the U.S. Patent and Trademark Office to protect the intellectual property. Industry partners interested in developing or commercializing the work should contact Joe Kasper, assistant director of business development and licensing — life sciences, at jrkasper@prf.org, about track codes 69967, 69996, 70004 and 70255.

In conjunction with World Parkinson’s Day, Dr. Fortin and her team are to be congratulated on their work to provide potential small molecule therapeutics for Parkinson’s disease. To learn more about innovation at Purdue, visit the Purdue Innovates website.

Writer(s): Steve Martin, Purdue Research Foundation | pvmnews@purdue.edu

Recent Stories

“Paws Up” – brought to you by the PVM Wellness Committee

We’d like to give a big “paws up” to Dr. Rachel Illgen, who is a small animal rotating intern in the Purdue University Veterinary Hospital.

Purdue Veterinary Student Named as National Theriogenology Scholarship Recipient

Congratulations to Devon Anderson, of the Purdue DVM Class of 2025, who recently was notified that he has been selected as one of just four recipients of the prestigious Nandi Theriogenology Scholarship. The award, given by the Society for Theriogenology, recognizes exceptional veterinary students from across North America who have demonstrated a strong commitment to the field of theriogenology — the study of animal reproduction.

Sunny Skies and Creative Exhibits Draw Hundreds to Annual PVM Open House

Sunrise on Saturday, April 12, brought the promise of a lovely spring day and large crowds for a beloved spring tradition at Lynn Hall on the Purdue University West Lafayette campus – the annual Purdue Veterinary Medicine Open House. Organized by PVM students, the day-long event is held each year as part of Purdue University’s Spring Fest celebration.

Cat Care, Comfort, and Extra Time

Today we begin a Vet Gazette series about animals and their owners who've found help and healing at the Purdue University Veterinary Hospital. Periodically we will share heartwarming tributes from hospital clients who wanted to highlight the vital care and treatment their animal companions received from the hospital's caring team of clinicians, veterinary nurses, staff and students. The first is the tale of a cat named Gabby.

New PVM Interim Assistant Dean for Clinical Education Named

As of this week, Dr. Wendy Townsend, professor of Ophthalmology in the Department of Veterinary Clinical Sciences, has begun serving as interim assistant dean for clinical education in the Purdue University College of Veterinary Medicine. Her appointment was effective Wednesday, April 16.

Nine PVM Faculty Members among Newly Promoted Purdue University Professors

The Purdue University Board of Trustees has approved the promotion of 163 faculty across the Purdue University system for the 2025-26 academic year, and a total of nine Purdue Veterinary Medicine faculty members are among the 137 promotees from the main campus.